Quince Therapeutics gains FDA Fast Track Designation for EryDex System - Pharmafile
Quince Therapeutics has announced that the US Food and Drug Administration (FDA) has granted Fast Track Designation for its EryDex System which focuses on the treatment of patients with Ataxia-Tela...
pharmafile.com